AzTrials
AzTrials

Body Weight ChangesNCT02966444

Hunger, Satiety, and Metabolic Responses to High-fat Meals of Varying Fatty Acid Composition

A study testing MUFA-rich HF Meal, PUFA-rich HF Meal and SFA-rich HF Meal in people with Body Weight Changes, run by Texas Christian University at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study evaluates the effects of dietary fatty acid composition from high fat meals on markers of hunger, satiety and metabolism. Read more about this study

Who is it for?
Ages 18 to 40 years, women onlyHealthy volunteers can take part
Conditions the study is for
Body Weight Changes
What is being tested?
MUFA-rich HF Meal, PUFA-rich HF Meal and SFA-rich HF Meal
Could I receive a placebo?
No, everyone receives an active treatment
How many people
16 participants
Where
1 siteUnited States
Study dates
Oct 2016to Jul 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • BMI of >18.5-24.9kg/m2
  • Woman
  • 18-40yrs of age

Who cannot join

  • Evidence of weight loss or gain exceeding 5% of their body weight within the past 3 months.
  • Plans to lose weight or begin a weight loss program between initiation of study and final testing.
  • Plans to begin an exercise program or change current exercise routines between initiation of study and final testing.
  • Is on a medically prescribed diet
  • Does not consume breakfast regularly
  • Rate less than 80% of foods offered in the buffet at 50mm or more on the 100mm VAS as palatable
Show all 13Show fewer
  • Medications that could influence appetite or sensory function
  • Reports of metabolic or endocrine disease, gastrointestinal disorders, or history of medical or surgical events that could affect fat digestion and hormone signaling.
  • Any chronic disease including type II diabetes, hypothyroidism, hyperthyroidism, cardiovascular disease, and cancer
  • Any supplements that a subject begins taking between initiation of study and final testing.
  • Anyone who is currently pregnant, lactating, or planning on becoming pregnant before the conclusion of this study.
  • Anyone who has allergies to any of the components of the liquid meals
  • Anyone who has donated blood in the last 20 days

Trial locations and contacts

1 site in 1 country.

Jada L Stevenson, PhD contact

817-257-6310

jada.stevenson@tcu.edu

United States1 site, 1 recruiting
  • Texas Christian University

    Fort Worth, Texas, 76102

    Jada L Stevenson, PhD, 817-257-6310, jada.stevenson@tcu.edu

    Recruiting

Other trials in United States

About this study

This study evaluates the effects of dietary fatty acid composition from high fat meals on markers of hunger, satiety and metabolism.

Being tested
MUFA-rich HF Meal, PUFA-rich HF Meal, SFA-rich HF Meal
Medical subject headings
Body Weight Changes

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MUFA-rich HF MealOther

  • PUFA-rich HF MealOther

  • SFA-rich HF MealOther

Study groups in NCT02966444
Study groupRoleWhat they receive
MUFA-rich HF MealExperimentalHigh-fat meal rich in monounsaturated fatty acids
Receives: Other: MUFA-rich HF Meal
PUFA-rich HF MealExperimentalHigh-fat meal rich in polyunsaturated fatty acids
Receives: Other: PUFA-rich HF Meal
SFA-rich HF MealExperimentalHigh-fat meal rich in saturated fatty acids
Receives: Other: SFA-rich HF Meal

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Peptide-YY

    Measured: 18 months

Secondary outcomes (1)
  1. Visual Analog Scale

    Measured: 18 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Nov 2016 (estimated)
  2. Study startOct 2016
  3. Primary completionJul 2018 (estimated)
  4. Study completionJul 2018 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Participant
Enrolment
16 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02966444
Sponsor's protocol ID
CT2016JS1
Status last verified
Jul 2018
First submitted
8 Nov 2016
Last updated
26 Jul 2018
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing MUFA-rich HF Meal, PUFA-rich HF Meal and SFA-rich HF Meal in people with Body Weight Changes, run by Texas Christian University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 26 Jul 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Jada L Stevenson, PhD (817-257-6310, jada.stevenson@tcu.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Peptide-YY (time frame: 18 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jul 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in